Featured Story | By Fraiser Kansteiner Novo Nordisk snagged Emisphere Technologies for $1.8 billion, aiming to use the company's tablet formulation technology to beef up its oral-drug offerings in diabetes and beyond. And it knows the Emisphere tech well—it's what made the oral GLP-1 med Rybelsus possible. read more |
| |
|---|
|
Top Stories By Angus Liu GlaxoSmithKline’s ViiV Healthcare has been hoping to bring its long-acting PrEP challenger cabotegravir to help both men and women prevent HIV. But that plan depended on very optimistic expectations for results from a head-to-head clinical trial against Gilead’s Truvada in women. Now, it has those data—one year ahead of schedule. read more By Fraiser Kansteiner In the hunt for safer and more effective delivery methods for cancer drugs, scientists are taking a cue from the natural armor that surrounds shrimp, insects and and other chitinous critters. A nanoparticle derived from those shells showed promise at cutting side effects and improving durability in a mouse study. read more By Nick Paul Taylor AstraZeneca has talked up the prospects of its anti-SARS-CoV-2 antibody working in severe COVID-19 patients despite rival assets from Eli Lilly and Regeneron failing in that population. Mene Pangalos, an AstraZeneca EVP, made the comments while sharing news the antibody is set to start a prophylaxis study next week. read more By Angus Liu China has witnessed a biotech boom over the past decade, and the first crop just started to bear fruit. Here, we spotlight 10 companies that we think everyone who takes an interest in China’s biotech industry should know about since they'll likely compete on the global stage one day. What sets them apart is that all but one of them have attracted foreign Big Pharma companies buying into their R&D. read more Resources Sponsored by: Veeva One sentence that will be displayed in the newsletter and should be written to grab the interest of your audience to want to read more. Sponsored by: Veeva One sentence that will be displayed in the newsletter and should be written to grab the interest of your audience to want to read more. Sponsored By: BioAnalytix Download this eBook and Learn the Advantages of LC-MS based HCP Profiling for Development of Complex Biologics. Sponsored by: Vituity With COVID-19 as the catalyst, empowered clinician leaders are creating solutions to challenges they face every day. Get white paper. Sponsored By: Polpharma Biologics Innovative cell lines and early process development are critical to generate a high producing cell lines alongside a USP strategy to meet high quality standards. Sponsored By: Medidata Responding to site challenges. Approaching virtualization. Leveraging real-time data. Medidata shares 8 parameters to implement your virtualization strategy during COVID-19 and beyond. Download Now. Sponsored by: Rousselot This infographic describes the benefits of GelMA in various biomedical applications and how X-Pure® GelMA can help you in your developments. Sponsored By: Lonza Liquid-filled hard capsule formulations offer unique options for the manufacture and dosing of highly potent actives. Sponsored By: Thermo Fisher Scientific One of the best ways to stay on-schedule is to start with a solid understanding of the most common API challenges. Awareness will help you choose a development partner with the ability to solve issues before they affect your timeline. Sponsored By: Clinical Ink This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations. Sponsored By: WCG Need additional site resources for your current or upcoming clinical trial? Sponsored By: Thermo Fisher Scientific Anticipate early development challenges to avoid rework and costs. Sponsored By: Cytiva Accelerating the production of viral-vector based therapy requires both understanding of strategies to address viral vector manufacturing and how to select the most cost-effective solution for your therapeutic. Read more in this article. Sponsored by: LexisNexis Risk Solutions Get insights into healthcare decision-makers networks. Sponsored By: Veeva Learn how to plan immersive digital event experiences Sponsored by: Aldevron Gene and cell therapy organizations are asked to balance the need for rapid clinical progression and stringent quality expectations throughout development. In this document, Aldevron provides an in-depth look at preparing for plasmid manufacturing based on our years of experience. Sponsored By: Elligo Health Research® Understanding the Challenges COVID-19 Pediatric Clinical Trials Face | White Paper Sponsored By: Outer Edge Technology A sound Cloud Strategy provides the flexibility and tools businesses need to quickly adapt and operate securely in an ever-changing remote work environment. Learn how your company can cost-effectively empower its employees to be productive and secure while working remotely. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Cascade Chemistry, API CDMO Struggling with complex chemistry to get APIs for clinical trials? Find out what to look for in an API CDMO partner to gain expertise and speed that lead to success. Sponsored by: Catalent Learn about proven strategies for a successful product launch, including cross-functional team collaboration, risk management and using the right project management tools. Sponsored by: Catalent This eBook provides insights on key approaches and considerations for preparing your drug development program for long-term success. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. Sponsored by: Formedix Learn how to save time and reduce costs and complexity by streamlining the clinical trial process. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Catalent Pharmaceutical and biotech companies are spending years developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. It’s a “race to the finish” in some cases, and the quicker a company can get its product to patients, the better. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. | 
